MicroRNA-142 regulates gut associated lymphoid tissues and group 3 innate lymphoid cells
Name:
PIIS1933021924000941.pdf
Size:
6.482Mb
Format:
PDF
Description:
Found with Open Access Button
Authors
Roberts, L. B.Neves, J. F.
Lee, D. C. H.
Valpione, Sara
Tachó-Piñot, R.
Howard, J. K.
Hepworth, M. R.
Lord, G. M.
Affiliation
The Christie NHS Foundation Trust, 550 Wilmslow Road, M20 4BX Manchester, United Kingdom; Division of Cancer Sciences, The University of Manchester, Oxford Road, M13 9PL Manchester, United Kingdom; Cancer Research UK National Biomarker Centre, Wilmslow Road, M20 4BX Manchester, United Kingdom.Issue Date
2024
Metadata
Show full item recordAbstract
The transcriptomic signatures that shape responses of innate lymphoid cells (ILCs) have been well characterised, however post-transcriptional mechanisms which regulate their development and activity remain poorly understood. We demonstrate that ILC groups of the intestinal lamina propria express mature forms of microRNA-142 (miR-142), an evolutionarily conserved microRNA family with several non-redundant regulatory roles within the immune system. Germline Mir142 deletion alters intestinal ILC compositions, resulting in the absence of T-bet(+) populations and significant defects in the cellularity and phenotypes of ILC3 subsets including CCR6(+) LTi-like ILC3s. These effects were associated with decreased pathology in an innate-immune cell driven model of colitis. Furthermore, Mir142(-/-) mice demonstrate defective development of gut-associated lymphoid tissues, including a complete absence of mature Peyer's patches. Conditional deletion of Mir142 in ILC3s (Rorc(Δ)(Mir142)) supported cell-intrinsic roles for these microRNAs in establishing or maintaining cellularity and functions of LTi-like ILC3s in intestinal associated tissues. RNAseq analysis revealed several target genes and biological pathways potentially regulated by miR-142 microRNAs in these cells. Finally, lack of Mir142 in ILC3 led to elevated IL-17A production. These data broaden our understanding of immune system roles of miR-142 microRNAs, identifying these molecules as critical post-transcriptional regulators of ILC3s and intestinal mucosal immunity.Citation
Roberts LB, Neves JF, Lee DCH, Valpione S, Tachó-Piñot R, Howard JK, et al. MicroRNA-142 regulates gut associated lymphoid tissues and group 3 innate lymphoid cells. Mucosal immunology. 2024 Sep 7. PubMed PMID: 39245145. Epub 2024/09/09. eng.Journal
Mucosal ImmunologyDOI
10.1016/j.mucimm.2024.09.001PubMed ID
39245145Additional Links
https://dx.doi.org/10.1016/j.mucimm.2024.09.001Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.mucimm.2024.09.001
Scopus Count
Collections
Related articles
- RIPK3 and caspase-8 interpret cytokine signals to regulate ILC3 survival in the gut.
- Authors: Joseph AM, Ahmed A, Goc J, Horn V, Fiedler B, Garone D, Grigg JB, Uddin J, Teng F, Fritsch M, Vivier E, Sonnenberg GF
- Issue date: 2024 Dec
- Investigating the impact of antibiotic-induced dysbiosis on protection from Clostridium difficile colitis by mouse colonic innate lymphoid cells.
- Authors: Uddin MJ, Thompson B, Leslie JL, Fishman C, Sol-Church K, Kumar P, Petri WA Jr
- Issue date: 2024 Mar 13
- Dynamic regulation of innate lymphoid cell development during ontogeny.
- Authors: Wu T, Chen S, Zhu X, Ma J, Luo M, Wang Y, Tian Y, Sun Q, Guo X, Zhang J, Zhang X, Zhu Y, Wu L
- Issue date: 2024 Dec
- GLP-1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells.
- Authors: Sun H, Shu J, Tang J, Li Y, Qiu J, Ding Z, Xuan B, Chen M, Gan C, Lin J, Qiu J, Sheng H, Wang C
- Issue date: 2024 Jul
- NRP1 instructs IL-17-producing ILC3s to drive colitis progression.
- Authors: Wang Y, Wang J, Liu G, Yi X, Wu J, Cao H, Zhang L, Zhou P, Fan Y, Yu Y, Liu Q, Yao Z, Wang H, Zhou J
- Issue date: 2025 Feb